Trial Profile
Ursodeoxycholic Acid Therapy in Chronic Heart Failure: A Placebo-Controlled Study Evaluating the Effects of Ursodeoxycholic Acid on Peripheral Blood Flow and Immune Function.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Ursodeoxycholic acid (Primary)
- Indications Chronic heart failure
- Focus Pharmacodynamics
- 07 Feb 2012 Results published in the Journal of the American College of Cardiology.
- 07 Oct 2006 New trial record.